Combination therapy in chronic hepatitis B: what are the real benefits?

Minerva Med. 2018 Apr;109(2):69-70. doi: 10.23736/S0026-4806.17.05474-X. Epub 2017 Nov 7.

Authors

Lucio Boglione¹, Giuseppe Cariti²

Affiliations

¹ Unit of Infectious Diseases, Department of Medical Sciences, Amedeo di Savoia Hospital, University of Turin, Turin, Italy - lucio.boglione@unito.it.
² Unit of Infectious Diseases, Department of Medical Sciences, Amedeo di Savoia Hospital, University of Turin, Turin, Italy.

PMID: 29115802
DOI: 10.23736/S0026-4806.17.05474-X

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents / therapeutic use*
Drug Therapy, Combination
Hepatitis B, Chronic / drug therapy*
Humans
Treatment Outcome

Substances

Antiviral Agents